Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) is pleased to announce that, on September 20, 2022, the marketing authorization for generics of Azilsartan tablets (specification: 20mg), developed and manufactured by the Group, has been obtained from the China National Medical Products Administration (“NMPA”) (國藥准字H20223680). The drug has been approved to treat hypertension.
English 
Thai